This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Zacks Industry Outlook Highlights Procter & Gamble, Church & Dwight, Ollie's Bargain Outlet and Grocery Outlet
by Zacks Equity Research
Consumer staples leaders are navigating rising costs and shifting consumer behavior while innovating to sustain growth.
4 Consumer Product Stocks Showing Resilience Amid Market Headwinds
by Zacks Equity Research
Despite rising costs and shifting consumer trends, PG, CHD, OLLI and GO are demonstrating resilience by implementing strategic measures to sustain growth.
Procter & Gamble (PG) Stock Falls Amid Market Uptick: What Investors Need to Know
by Zacks Equity Research
In the most recent trading session, Procter & Gamble (PG) closed at $157.35, indicating a -1.32% shift from the previous trading day.
Procter & Gamble Company (The) (PG) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
P&G (PG) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
P&G (PG) Is Considered a Good Investment by Brokers: Is That True?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), P&G (PG) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Procter & Gamble vs. Colgate: Which Household Staple Is a Better Pick?
by Rajani Lohia
PG's vast scale and CL's focused specialization showcase two distinct strategies shaping the evolving landscape of global consumer staples.
The Zacks Analyst Blog Highlights Lilly, Oracle, Procter & Gamble and Comstock Holding Companies
by Zacks Equity Research
Zacks spotlights Eli Lilly, Oracle, Procter & Gamble, and microcap Comstock Holding, with pharma and staples facing pressure while Oracle and Comstock show momentum.
Top Stock Reports for Eli Lilly, Oracle & Procter & Gamble
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly, Oracle, and Procter & Gamble, as well as a micro-cap stock, Comstock.
P&G (PG) Up 2.7% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
P&G (PG) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Procter & Gamble's Innovation Playbook: Working or Wearing Thin?
by Zacks Equity Research
PG leans on bold product launches like Tide evo and Swiffer PowerMop, but questions remain on whether innovation can keep fueling growth.
Investors Heavily Search Procter & Gamble Company (The) (PG): Here is What You Need to Know
by Zacks Equity Research
P&G (PG) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Here's Why Procter & Gamble (PG) Fell More Than Broader Market
by Zacks Equity Research
In the closing of the recent trading day, Procter & Gamble (PG) stood at $156.15, denoting a -1.59% move from the preceding trading day.
Will Slowing Global Demand Dent PG's Emerging Market Strategy?
by Zacks Equity Research
Procter & Gamble's emerging market strength in Latin America and India shows resilience despite global demand concerns.
Procter & Gamble Exhibits High P/E: A Buy Opportunity or Time to Wait?
by Rajani Lohia
PG posts solid growth and dividend strength, but its high valuation sparks debate on whether the stock is worth buying now.
Will Colgate's Innovation Drive Market Share Gains in 2025?
by Zacks Equity Research
CL's innovation push spans premium oral, personal, home and pet care to drive market share growth in 2025 despite headwinds.
Here is What to Know Beyond Why Procter & Gamble Company (The) (PG) is a Trending Stock
by Zacks Equity Research
Zacks.com users have recently been watching P&G (PG) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
PG vs. Inflation: How Long Can Price Hikes Offset Input Costs?
by Zacks Equity Research
Procter & Gamble faces slowing category growth as inflation and tariffs challenge its long-running price hike strategy.
Procter & Gamble's Margins Stay Firm: Is Premiumization Paying Off?
by Zacks Equity Research
PG expands core margins and grows EPS despite volatility, signaling the strength of its premiumization strategy.
Procter & Gamble Company (The) (PG) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to P&G (PG). This makes it worthwhile to examine what the stock has in store.
Procter & Gamble Stock Rises on Q4 Earnings & Sales Beat, Strong View
by Zacks Equity Research
The PG stock climbs after Q4 earnings and sales top estimates, driven by broad segment gains and a strong fiscal 2026 forecast.
P&G (PG) Reports Q4 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
The headline numbers for P&G (PG) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Procter & Gamble (PG) Q4 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
P&G (PG) delivered earnings and revenue surprises of +3.50% and +0.39%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
S&P 500 & Nasdaq Notch New All-Time Closing Highs
by Mark Vickery
Markets lost a bit of steam mid-session this Monday, but a late surge into the close brought the S&P 500 and the Nasdaq indexes to new record closing highs.
Heavy-Duty Earnings Week Commences
by Zacks Equity Research
Heavy-Duty Earnings Week Commences.
Big Week for Jobs, Earnings and the Fed
by Mark Vickery
There's only a 2% chance the Fed has enough votes to cut to outstrip Fed Chair Powell's opinion to keep interest rates where they are.